Abstract:Background IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide and is a leading cause of renal failure. The disease mechanisms are not completely understood, but a higher abundance of galactose-deficient IgA is recognized to play a crucial role in IgAN pathogenesis. Although both types of human IgA (IgA1 and IgA2) have several N -glycans as post-translational modification, only IgA1 features extensive hinge-region O -glycosylation. IgA1 galactose deficiency on the O -glycans is commonly detected by a lectin-based method. To date, limited detail is known about IgA O- and N- glycosylation in IgAN. Methods To gain insights into the complex O- and N -glycosylation of serum IgA1 and IgA2 in IgAN, we used liquid chromatography-mass spectrometry (LC-MS) for the analysis of tryptic glycopeptides of serum IgA from 83 patients with IgAN and 244 age- and sex-matched healthy controls. Results Multiple structural features of N- glycosylation of IgA1 and IgA2 were associated with IgAN and glomerular function in our cross-sectional study. These features included differences in galactosylation, sialylation, bisection, fucosylation, and N- glycan complexity. Moreover, IgA1 O- glycan sialylation was associated with both the disease and glomerular function. Finally, glycopeptides were a better predictor of IgAN and glomerular function than galactose-deficient IgA1 levels measured by lectin-based ELISA. Conclusions Our high-resolution data suggest that IgA O - and N- glycopeptides are promising targets for future investigations on the pathophysiology of IgAN and as potential noninvasive biomarkers for disease prediction and deteriorating kidney function. Significance Statement IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide, with galactose-deficient IgA (gd-IgA) considered to play a key role in its pathogenesis. Although this association is widely reported, it is unclear how IgA glycosylation changes with the disease. A novel mass spectrometry–based approach provided a more complete picture of IgA glycosylation changes in IgAN and of the relationship between IgA glycosylation and kidney function. Multiple structural features of both O- and N -linked glycans were associated with the presence and severity of IgAN and kidney function. Our high-resolution data suggest that IgA O - and N- glycopeptides are promising targets for future studies on the pathophysiology of IgAN and as potential noninvasive biomarkers for disease prediction. Visual

Maintenance of the ionic composition of the incubated artery.

Progress in Pathogenesis of Immunoglobin A Nephropathy

IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy

O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy

NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy

Immunoglobulin Glycosylation Effects in Allergy and Immunity

New Insights into the Pathogenesis of IgA Nephropathy

Reduced ACTH Content in Cerebrospinal Fluid of Children Affected by Cryptogenic Infantile Spasms with Hypsarrhythmia

Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system

[Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis]

O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function

Detections of Yersinia pestis East of the Known Distribution of Active Plague in the United States.

PROBLEMS RELATED TO ALCOHOL USE: A CROSS-CULTURAL PERSPECTIVE

The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis

Deciphering roles of protein post-translational modifications in IgA nephropathy progression and potential therapy

Aberrantly Glycosylated Serum IgA1 Are Closely Associated with Pathologic Phenotypes of IgA Nephropathy.

Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases

A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease